Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colostrum Supplements in Healthy Subjects and Type 2 Diabetes
NCT06007430Phase 2Completed
- Sponsor
- Al-Mustafa University College
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (4 arms), sponsored by Al-Mustafa University College. Primary endpoints: Serum interleukin-1 at 60 days, Serum interleukin-15 at 60 days and 3 more. Started Mar 2023; status: completed.
Beyond the preview
Go deeper on NCT06007430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06007430.